Not applicableWithdrawnNCT01781442What this trial is testingA Post Marketing Surveillance As Required By Philippine Food And Drug AdministrationWho this might be right forRenal Cell Carcinoma Pfizer
Large-scale testing (Phase 3)Study completedNCT00732914What this trial is testingSequential Study to Treat Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Sponsor GmbH 272
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 120
Testing effectiveness (Phase 2)Study completedNCT00792025What this trial is testingSunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Institut Curie 80
Early research (Phase 1)Looking for participantsNCT05759923What this trial is testingFirst-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid TumoursWho this might be right forAdvanced Ovarian CarcinomaAdvanced Renal Cell CarcinomaAdvanced Pancreatic Carcinoma+5 more Molecure S.A. 40
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Early research (Phase 1)Looking for participantsNCT07195682What this trial is testingA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)Who this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 281
Testing effectiveness (Phase 2)Study completedNCT00066612What this trial is testingS0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 45
Not applicableStudy completedNCT00684645What this trial is testingNon-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®Who this might be right forMetastatic Renal Cell Carcinoma Pfizer 186
Testing effectiveness (Phase 2)Study completedNCT03679767What this trial is testingINCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)Who this might be right forMetastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more Incyte Corporation 121
Testing effectiveness (Phase 2)Ended earlyNCT00303862What this trial is testingAZD2171 in Treating Patients With Refractory Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT04337970What this trial is testingTalazoparib and Axitinib for People With Previously Treated Advanced Kidney CancerWho this might be right forKidney CancerRenal Cell CarcinomaUnresectable Renal Cell Carcinoma+1 more Memorial Sloan Kettering Cancer Center 23
Early research (Phase 1)Study completedNCT02655822What this trial is testingPhase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced CancersWho this might be right forRenal Cell CancerMetastatic Castration Resistant Prostate Cancer Corvus Pharmaceuticals, Inc. 502
Testing effectiveness (Phase 2)Ended earlyNCT05935748What this trial is testingPh2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)Who this might be right forccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more NiKang Therapeutics, Inc. 18
Not applicableStudy completedNCT00610012What this trial is testingTumor Registry of Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma iOMEDICO AG 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT03091192What this trial is testingSavolitinib vs. Sunitinib in MET-driven PRCC.Who this might be right forCarcinomaCarcinoma, Renal CellKidney Neoplasms+5 more AstraZeneca 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081What this trial is testingTesting Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 TrialWho this might be right forMetastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Study completedNCT03126110What this trial is testingPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179